Products & ServicesEvent: September 3, 2026
Eurofins Transplant Genomics introduced Eurofins TRAC Plus ID, a whole genome sequencing platform that analyzes a single sample for two distinct signals, donor-derived cell-free DNA and microbial sequences including viral targets such as TTV.
Published
Signal category
Products & Services
Quote
“Eurofins TRAC™ plus ID uses whole genome sequencing to analyze a single sample for two distinct signals”
— Eurofins Transplant Genomics team
Company
Eurofins Transplant Genomics
Transplant Genomics improves organ transplant outcomes through molecular diagnostic tests.
- Industry
- Biotechnology Research
- Location
- Framingham, US
- Company size
- 40 employees
Transplant Genomics is committed to improving organ transplant outcomes with noninvasive serial monitoring guided by genomics.
Founded 2013